Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
Free Webinar - Master Forex Trading Today! Don't Miss Out | Tuesday, June 6, 2023 | 01:00PM EDT Enroll Now
Close

DiaSorin SpA (0GZX)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
97.35 -1.09    -1.10%
11:39:30 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  United Kingdom
ISIN:  IT0003492391 
SEDOL:  B2900H1
  • Volume: 14,806
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 97.35 - 97.35
Diasorin 97.35 -1.09 -1.10%

0GZX Balance Sheet

 
Featured here, the Balance Sheet for DiaSorin SpA, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2023
31/03
 2022
31/12
 2022
30/09
 2022
30/06
Total Current Assets 797.1 1074.21 1074.21 979.25
Cash and Short Term Investments 372.6 384.18 384.18 382.44
Cash - - - -
Cash & Equivalents 372.6 241.78 241.78 382.44
Short Term Investments - 142.41 142.41 -
Total Receivables, Net - 241.35 241.35 261.42
Accounts Receivables - Trade, Net - 220.04 220.04 201.22
Total Inventory - 306.5 306.5 313.39
Prepaid Expenses - - - -
Other Current Assets, Total 424.5 142.17 142.17 22
Total Assets 3046.1 3408.08 3408.08 3438.05
Property/Plant/Equipment, Total - Net 260.1 268.45 268.45 289.87
Property/Plant/Equipment, Total - Gross - 555.27 555.27 -
Accumulated Depreciation, Total - -286.82 -286.82 -
Goodwill, Net - 826.35 826.35 855.99
Intangibles, Net 1953.5 1168.71 1168.71 1236.88
Long Term Investments - 0.026 0.026 0.026
Note Receivable - Long Term - 21.32 21.32 60.2
Other Long Term Assets, Total 35.4 52.34 52.34 50
Other Assets, Total 424.5 367.73 367.73 100
Total Current Liabilities - 347.02 347.02 233.68
Accounts Payable - 104.2 104.2 75.49
Payable/Accrued - - - -
Accrued Expenses - 67.68 67.68 78.19
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - 120.02 120.02 59.08
Other Current liabilities, Total - 55.11 55.11 20.92
Total Liabilities 1518.9 1888.33 1888.33 1892.52
Total Long Term Debt 1221.3 1231.96 1231.96 1372.14
Long Term Debt 1221.3 1170.96 1170.96 1305.29
Capital Lease Obligations - 61 61 66.85
Deferred Income Tax - 229.31 229.31 200.11
Minority Interest - 0.761 0.761 0.894
Other Liabilities, Total 297.6 -715 79.28 -825.07
Total Equity 1527.2 1519.75 1519.75 1545.53
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 1527.2 55.95 55.95 55.95
Additional Paid-In Capital - 18.16 18.16 18.16
Retained Earnings (Accumulated Deficit) - 1641.44 1641.44 1446.28
Treasury Stock - Common - -281.28 -281.28 -185.69
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - 85.49 85.49 210.84
Total Liabilities & Shareholders' Equity 3046.1 3408.08 3408.08 3438.05
Total Common Shares Outstanding - 53.51 53.51 54.2
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

DIAS Comments

Write your thoughts about DiaSorin
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Alessandro To
Alessandro To Apr 13, 2023 12:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
E comunwue oggi incremento . Bilanci dal 2020 raddoppiati.
Reply
0 0
Report
Tobias Raeder
Tobias Raeder Jun 02, 2021 10:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Che successe, mentre il resto sale?
Reply
1 0
Report
Tobias Raeder
Tobias Raeder Jun 02, 2021 10:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
superata la curva alta di Bollinger,  punta a 160 ?
Reply
2 0
Report
Robin Clerici
Robin Clerici Jun 02, 2021 10:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Tobias Raeder well said! It did it now
Reply
1 0
Report
Jhon Lucy
Jhon Lucy May 26, 2020 10:25AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Overrated company, in my opinion you can sell Short Diasorin capitalization 11 billion euros Profits 175 million euros Turnover 800 million ISIN IT0003492391 diasorin
Reply
2 7
Report
Saverio Daquino
Saverio Daquino May 25, 2020 2:01PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
short!!
Reply
1 7
Report
giulio corsi
giucor Apr 25, 2020 11:48AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
alla faccia del fattoquotidiano che oggi ha provato a dare un'altra spallata a questo gioiello... Coronavirus: da Fda via libera a test sierologico DiaSorin L'autorizzazione per analisi validata al San Matteo di Pavia (ANSA) - ROMA, 25 APR - DiaSorin annuncia di aver ricevuto l'Emergency Use Authorization (EUA) dalla Food and Drug Administration americana per il test LIAISON  SARS-CoV-2 S1/S2 IgG. Si tratta del nuovo test sierologico validato presso il Policlinico San Matteo a Pavia, uno dei centri di riferimento nazionali per la pandemia da COVID-19.
Reply
3 3
Report
Sam Lloyd
Sam Lloyd Mar 20, 2020 3:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
DIASORIN COVID fast test has been approved by FDA
Reply
9 0
Report
luca cas
luca cas Mar 20, 2020 3:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
nice news, not sure why is going down anyway
Reply
0 0
Report
Roby Carati
Roby Carati Mar 20, 2020 3:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
When??????
Reply
0 0
Report
Dario Fazio
Dario Fazio Mar 13, 2020 5:28PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
USA: Dow e NASDAQ han chiuso a +10%. Lunedì si parte da 120.10€. Buon weekend
Reply
2 1
Report
Captain USD
Captain USD Mar 13, 2020 5:28PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
E invece... 109.90€ :D
Reply
1 0
Report
Enea Caccamese
Enea Caccamese Mar 13, 2020 11:26AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
DiaSorin’s test could be ready within six weeks for consideration by the U.S. Food and Drug Administration, and the QIAGEN test could be ready within 12 weeks for FDA consideration, according to HHS.
Reply
0 0
Report
Sam Lloyd
Sam Lloyd Mar 11, 2020 11:46AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
They just announced a fast test for COVID-19, 60 minutes against some hours
Reply
2 0
Report
Scotti Davide
SDavide Feb 04, 2020 8:22PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
150€ during this year ?
Reply
2 1
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email